HemaSphere (Aug 2023)
P519: RISK STRATIFICATION BY NOMOGRAM SCORING SYSTEM OF NPM1-MUTATED CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIALEUKAEMIA BASED ON A MULTI-GENE PANEL
- Mingyue Zhao,
- Yalan Zhou,
- Hao Jiang,
- Leiming Cao,
- Lixin Wu,
- Lixia Liu,
- Jiayue Qin,
- Shanbo Cao,
- Yingjun Chang,
- Qian Jiang,
- Lanping Xu,
- Xiaohui Zhang,
- Xiaojun Huang,
- Guorui Ruan
Affiliations
- Mingyue Zhao
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Yalan Zhou
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Hao Jiang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Leiming Cao
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Lixin Wu
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Lixia Liu
- 2 Acornmed Biotechnology Co. Ltd., Tianjin, China
- Jiayue Qin
- 2 Acornmed Biotechnology Co. Ltd., Tianjin, China
- Shanbo Cao
- 2 Acornmed Biotechnology Co. Ltd., Tianjin, China
- Yingjun Chang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Qian Jiang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Lanping Xu
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Xiaohui Zhang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Xiaojun Huang
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- Guorui Ruan
- 1 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
- DOI
- https://doi.org/10.1097/01.HS9.0000968984.25232.da
- Journal volume & issue
-
Vol. 7
p. e25232da
Abstract
No abstracts available.